1 to 10 of 48
Sort by

Web Page
Immune Effector Cell-Related Adverse Events Immunotherapy Guideline

SITC Cancer Immunotherapy Guidelines are a collection of clinical practice guidelines (CPGs) developed by multi-disciplinary panels of experts who draw from their own practical experience as well as evidence in the published literature and clinical trial data to develop evidence- and consensus...

Pan Tumor Webinar Series: Refining Patient Selection for Biomarker-Directed Immunotherapy

Presented by PlatformQ in collaboration with the Society for Immunotherapy of Cancer As diagnostic and therapeutic advances intersect, there is a significant impact on oncology patient care and increased the use of molecular testing to guide treatment decision-making. While these practices are...

 06-10-2020 | 12:00 - 13:00 ET

Library Entry
Challenges in assessing the clinical utility and economic value of immune checkpoint inhibitor therapies of cancer

Advances in the immunotherapy of cancer have prolonged survival for cancer patients, but the clinical and financial impact of treatments must be considered in determining the overall clinical utility and economic value of therapeutic agents. Quality-adjusted life years and incremental cost...